Accelerate Diagnostics (NASDAQ: AXDX)
Some price data may be temporarily unavailable.
Accelerate Diagnostics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Accelerate Diagnostics Company Info
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The firm's products include Accelerate Pheno and Accelerate PhenoTest. The company was founded in 1982 and is headquartered in Tucson, AZ.
News & Analysis
This In Vitro Diagnostics Company Is Poised to Capture Its Share of a Growing Market
Its new system marks a groundbreaking advance in the field of testing for bloodstream infections.
Up 6% in June, Is Accelerate Diagnostics a Good Buy Now?
Investors were encouraged by a recent award the company received in the effort to diagnose and treat sepsis more rapidly.
Accelerate Diagnostics Announces Emergency Use Authorization for Covid-19 Antibody Test
This new testing platform will speed up health checks by determining whether asymptomatic people have COVID-19 antibodies in 30 minutes.
Why Accelerate Diagnostics Inc Is Soaring Today
Shares jump after the FDA gives the green light to two of the company's products.
3 Stocks Crushed by the Market This Week
No pops and sizzles for these stocks. Just drops and fizzles.
3 Stocks Near 52-Week Highs Worth Selling
Are these three stocks sells or belles? You be the judge!
3 Horrendous Health-Care Stocks This Week
It's a not-so-happy new year so far for Accelerate Diagnostics, Myriad Genetics, and Inovio. Here's why.
Valuation
Earnings Transcripts
Accelerate Diagnostics (AXDX) Q1 2020 Earnings Call Transcript
AXDX earnings call for the period ending March 31, 2020.
Accelerate Diagnostics (AXDX) Q4 2019 Earnings Call Transcript
AXDX earnings call for the period ending December 31, 2019.
Accelerate Diagnostics (AXDX) Q3 2019 Earnings Call Transcript
AXDX earnings call for the period ending September 30, 2019.
Accelerate Diagnostics (AXDX) Q2 2019 Earnings Call Transcript
AXDX earnings call for the period ending June 30, 2019.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.